How do we use biologics in rheumatoid arthritis patients with a history of malignancy? An assessment of treatment patterns using Scandinavian registers

Katerina Chatzidionysiou; Bénédicte Delcoigne; Thomas Frisell; Merete L Hetland; Bente Glintborg; Lene Dreyer; René Cordtz; Kristian Zobbe; Dan Nordström; Nina Trokovic; Kalle Aaltonen; Sella Aarrestad Provan; Gerdur Grondal; Bjorn Gudbjornsson; Johan Askling

doi:10.1136/rmdopen-2020-001363

How do we use biologics in rheumatoid arthritis patients with a history of malignancy? An assessment of treatment patterns using Scandinavian registers

RMD Open. 2020 Sep;6(2):e001363. doi: 10.1136/rmdopen-2020-001363.

Authors

Katerina Chatzidionysiou¹, Bénédicte Delcoigne², Thomas Frisell², Merete L Hetland^{3

4}, Bente Glintborg^{3

4}, Lene Dreyer^{5

6}, René Cordtz⁷, Kristian Zobbe⁷, Dan Nordström⁸, Nina Trokovic⁸, Kalle Aaltonen⁹, Sella Aarrestad Provan¹⁰, Gerdur Grondal¹¹, Bjorn Gudbjornsson¹², Johan Askling²

Affiliations

¹ Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Karolinska Institutet Department of Medicine Solna, Stockholm, Sweden aikaterini.chatzidionysiou@ki.se.
² Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Karolinska Institutet Department of Medicine Solna, Stockholm, Sweden.
³ DANBIO and Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre of Head and Orthopedics, Rigshospitalet, Copenhagen, Denmark.
⁴ Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
⁵ Department of Rheumatology, Aalborg University Hospital, Aalborg, Denmark.
⁶ Department of Clinical Medicine, Aalborg Universitet, Aalborg, Denmark.
⁷ Center for Rheumatology and Spine Diseases, Rigshospitalet, Gentofte Hospital, The Parker Institute, Frederiksberg Hospital Parker Institute, Frederiksberg, Denmark.
⁸ Helsinki University and Hospital (ROB-FIN), Departments of Medicine and Rheumatology, Helsinki University Central Hospital, Helsinki, Finland.
⁹ Pharmaceuticals Pricing Board, Ministry of Social Affairs and Health, Helsinki, Finland.
¹⁰ Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.
¹¹ Department of Rheumatology and Centre for Rheumatology Research, National University Hospital of Iceland, Reykjavik, Iceland.
¹² Centre for Rheumatology Research, University Hospital, and Faculty of Medicine, University of Iceland, Reykjavik, Iceland.

No abstract available

Keywords: Arthritis; Biological Therapy; Epidemiology; Rheumatoid.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Antirheumatic Agents / administration & dosage
Antirheumatic Agents / adverse effects
Antirheumatic Agents / therapeutic use*
Arthritis, Rheumatoid / complications
Arthritis, Rheumatoid / drug therapy*
Arthritis, Rheumatoid / epidemiology*
Arthritis, Rheumatoid / etiology
Biological Products / administration & dosage
Biological Products / adverse effects
Biological Products / therapeutic use*
Clinical Decision-Making
Disease Management
Humans
Neoplasms / complications
Neoplasms / epidemiology*
Practice Patterns, Physicians'*
Registries
Scandinavian and Nordic Countries / epidemiology
Treatment Outcome

Substances

Antirheumatic Agents
Biological Products